These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 33751995)

  • 1. Structural insights on the interaction potential of natural leads against major protein targets of SARS-CoV-2: Molecular modelling, docking and dynamic simulation studies.
    Skariyachan S; Gopal D; Muddebihalkar AG; Uttarkar A; Niranjan V
    Comput Biol Med; 2021 May; 132():104325. PubMed ID: 33751995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural and molecular basis of the interaction mechanism of selected drugs towards multiple targets of SARS-CoV-2 by molecular docking and dynamic simulation studies- deciphering the scope of repurposed drugs.
    Skariyachan S; Gopal D; Chakrabarti S; Kempanna P; Uttarkar A; Muddebihalkar AG; Niranjan V
    Comput Biol Med; 2020 Nov; 126():104054. PubMed ID: 33074111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbon fullerene and nanotube are probable binders to multiple targets of SARS-CoV-2: Insights from computational modeling and molecular dynamic simulation studies.
    Skariyachan S; Gopal D; Deshpande D; Joshi A; Uttarkar A; Niranjan V
    Infect Genet Evol; 2021 Dec; 96():105155. PubMed ID: 34823028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response regulator GacA and transcriptional activator RhlR proteins involved in biofilm formation of Pseudomonas aeruginosa are prospective targets for natural lead molecules: Computational modelling, molecular docking and dynamic simulation studies.
    Skariyachan S; Ravishankar R; Gopal D; Muddebihalkar AG; Uttarkar A; Praveen PKU; Niranjan V
    Infect Genet Evol; 2020 Nov; 85():104448. PubMed ID: 32622078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitogen activated protein kinase-1 and cell division control protein-42 are putative targets for the binding of novel natural lead molecules: a therapeutic intervention against
    Gopal D; Muddebihalkar AG; Skariyachan S; C AU; Kaveramma P; Praveen U; Shankar RR; Venkatesan T; Niranjan V
    J Biomol Struct Dyn; 2020 Sep; 38(15):4584-4599. PubMed ID: 31625462
    [No Abstract]   [Full Text] [Related]  

  • 6. Carboxymuconolactone decarboxylase is a prospective molecular target for multi-drug resistant Acinetobacter baumannii-computational modeling, molecular docking and dynamic simulation studies.
    Rana S; Skariyachan S; Uttarkar A; Niranjan V
    Comput Biol Med; 2023 May; 157():106793. PubMed ID: 36944292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computational Search for Potential COVID-19 Drugs from Ayurvedic Medicinal Plants to Identify Potential Inhibitors against SARS-CoV-2 Targets.
    Alagarsamy V; Solomon VR; Sundar PS; Kulkarni VS; Sulthana MT; Aishwarya AD; Narendhar B; Murugesan S
    Curr Comput Aided Drug Des; 2023; 19(1):51-67. PubMed ID: 36424783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of Effective Therapeutic Molecule from Natural Sources against Coronavirus Protease.
    Fadaka AO; Sibuyi NRS; Martin DR; Klein A; Madiehe A; Meyer M
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502340
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Maurya AK; Mishra N
    J Biomol Struct Dyn; 2021 Nov; 39(18):7306-7321. PubMed ID: 32835632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbon fullerene acts as potential lead molecule against prospective molecular targets of biofilm-producing multidrug-resistant
    Skariyachan S; Gopal D; Kadam SP; Muddebihalkar AG; Uttarkar A; Niranjan V
    J Biomol Struct Dyn; 2021 Feb; 39(3):1121-1137. PubMed ID: 32036742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computational design of prospective molecular targets for Burkholderia cepacia complex by molecular docking and dynamic simulation studies.
    Skariyachan S; Praveen PKU; Uttarkar A; Niranjan V
    Proteins; 2023 Jun; 91(6):724-738. PubMed ID: 36601892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational study for identifying promising therapeutic agents of hydroxychloroquine analogues against SARS-CoV-2.
    Prasanth DSNBK; Murahari M; Chandramohan V; Guntupalli C; Atmakuri LR
    J Biomol Struct Dyn; 2022; 40(22):11822-11836. PubMed ID: 34396938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic virtual screening in search of SARS CoV-2 inhibitors against spike glycoprotein: pharmacophore screening, molecular docking, ADMET analysis and MD simulations.
    Dhameliya TM; Nagar PR; Gajjar ND
    Mol Divers; 2022 Oct; 26(5):2775-2792. PubMed ID: 35132518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computational Evidences of Phytochemical Mediated Disruption of PLpro Driven Replication of SARS-CoV-2: A Therapeutic Approach against COVID-19.
    Balkrishna A; Mittal R; Arya V
    Curr Pharm Biotechnol; 2021; 22(10):1350-1359. PubMed ID: 33176643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying non-nucleoside inhibitors of RNA-dependent RNA-polymerase of SARS-CoV-2 through per-residue energy decomposition-based pharmacophore modeling, molecular docking, and molecular dynamics simulation.
    Aziz S; Waqas M; Mohanta TK; Halim SA; Iqbal A; Ali A; Khalid A; Abdalla AN; Khan A; Al-Harrasi A
    J Infect Public Health; 2023 Apr; 16(4):501-519. PubMed ID: 36801630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-based virtual screening, molecular dynamics and binding affinity calculations of some potential phytocompounds against SARS-CoV-2.
    Naik SR; Bharadwaj P; Dingelstad N; Kalyaanamoorthy S; Mandal SC; Ganesan A; Chattopadhyay D; Palit P
    J Biomol Struct Dyn; 2022 Sep; 40(15):6921-6938. PubMed ID: 33682632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacophore screening to identify natural origin compounds to target RNA-dependent RNA polymerase (RdRp) of SARS-CoV2.
    Mishra A; Rathore AS
    Mol Divers; 2022 Oct; 26(5):2613-2629. PubMed ID: 35000060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plant derived active compounds as potential anti SARS-CoV-2 agents: an
    Kashyap D; Jakhmola S; Tiwari D; Kumar R; Moorthy NSHN; Elangovan M; Brás NF; Jha HC
    J Biomol Struct Dyn; 2022; 40(21):10629-10650. PubMed ID: 34225565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening of potent phytochemical inhibitors against SARS-CoV-2 protease and its two Asian mutants.
    Muhammad I; Rahman N; Gul-E-Nayab ; Niaz S; Basharat Z; Rastrelli L; Jayanthi S; Efferth T; Khan H
    Comput Biol Med; 2021 Jun; 133():104362. PubMed ID: 33894500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing.
    Kumar Y; Singh H; Patel CN
    J Infect Public Health; 2020 Sep; 13(9):1210-1223. PubMed ID: 32561274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.